Comparison of Programmable and Non-programmable CSF Shunts Among Adult Hydrocephalus Patients With Different Etiologies

NCT05534659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 325

Last updated 2022-09-16

No results posted yet for this study

Summary

Programmable valve (PV) has been shown as a solution to the high revision rate in pediatric hydrocephalus patients, but it remains controversial among adults. This study is to compare the overall revision rate, revision cause, and revision-free survival between PV and non-programmable valve (NPV) in adult patients with different hydrocephalus etiologies.

Conditions

  • Hydrocephalus
  • Ventriculoperitoneal Shunt Malfunction

Interventions

DEVICE

Programmable valve

Programmable valve used in the study included Medtronic Strata, B-Braun ProGav, Codman Certas.

DEVICE

Non-programmable valve

Non-programmable valve used in the study was Medtronic CSF-flow control valve.

Sponsors & Collaborators

  • Ministry of Science and Technology, Taiwan

    collaborator OTHER_GOV
  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • ZHUO HAO Liu, PhD · Department of Neurosurgery Chang Gung Memorial Hospital Chang Gung Medical College and University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-03-01
Completion
2022-07-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534659 on ClinicalTrials.gov